Intelligence · Clinical Development
Pipeline search results
Programs matching “mtx” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 11 pipeline programs matching "mtx" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Infliximab + methotrexate (IFX + MTX)
Universal Integrated
Arthritis, Psoriatic
1 trial -
MC-MTX.18/AD
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
moderate to severe atopic dermatitis
1 trial -
MTX
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gestational Trophoblastic Tumor
1 trial -
MTX230-301
Biodexa Pharmaceuticals Plc
Familial adenomatous polyposis (FAP)
1 trial -
Natrunix with MTX placebo (+folate)
XBiotech Germany GmbH
Rheumatoid Arthritis
1 trial -
OMTX705-004
Lacuna Pharma Pty Ltd
Advanced/metastatic colorectal cancer
1 trial -
OMTX705-005
Lacuna Pharma Pty Ltd
Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer
1 trial -
MTX110
Biodexa Pharmaceuticals Plc
Recurrent Glioblastoma
1 trial -
OMTX705-001
Lacuna Pharma Pty Ltd
Selected tumor indications that are known to express FAP (Fibroblast activation protein) either on tumor stroma CAFs (Cancer-associated fibroblasts) (carcinomas) or on tumor cells (leiomyosarcomas and other sarcomas).
1 trial -
OMTX705-006 Phase 1b
Lacuna Pharma Pty Ltd
Advanced/Metastatic Pancreatic Adenocarcinoma
1 trial -
methotrexate (MTX)
AbbVie
Psoriatic Arthritis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.